Four polymorphisms of VEGF (+405C>G,-460T>C,-2578C>A, and-1154G>A) in susceptibility to psoriasis: A meta-analysis

DNA and Cell Biology

Volumn 33, Issue 4, 2014, Pages 234-244

  Qi, Min ^a   Huang, Xiaoyuan ^a   Zhou, Lei ^a   Zhang, Jianglin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYSTEINE; GLYCINE; THREONINE; VASCULOTROPIN;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; ASIAN; BIBLIOGRAPHIC DATABASE; CASE CONTROL STUDY; CAUCASIAN; CLINICAL EVALUATION; EMBASE; ENVIRONMENTAL EXPOSURE; ETHNIC GROUP; GENE EXPRESSION; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MEDLINE; META ANALYSIS; MICROARRAY ANALYSIS; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSORIASIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SAMPLE SIZE; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

ASIAN CONTINENTAL ANCESTRY GROUP; DATABASES, BIBLIOGRAPHIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINEAR MODELS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PSORIASIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84897389045     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2013.2252     Document Type: Article

References (47)

1. Aroni, K., Tsagroni, E., Kavantzas, N., Patsouris, E., and Ioannidis, E. (2008). A study of the pathogenesis of rosacea: how angiogenesis and mast cells may participate in a complex multifactorial process. Arch Dermatol Res 300, 125-131.
2. Awata, T., Inoue, K., Kurihara, S., Ohkubo, T., Watanabe, M., Inukai, K., et al. (2002). A common polymorphism in the 5-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51, 1635-1639.
3. Barbera-Guillem, E., Nyhus, J.K., Wolford, C.C., Friece, C.R., and Sampsel, J.W. (2002). Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. Cancer Res 62, 7042-7049.
4. Barile, S., Medda, E., Nistico, L., Bordignon, V., Cordiali-Fei, P., Carducci, M., et al. (2006). Vascular endothelial growth factor gene polymorphisms increase the risk to develop psoriasis. Exp Dermatol 15, 368-376.
5. Braverman, I.M., and Sibley, J. (1982). Role of the microcirculation in the treatment and pathogenesis of psoriasis. J Invest Dermatol 78, 12-17.
6. Brenchley, P.E. (2000). Angiogenesis in inflammatory joint disease: a target for therapeutic intervention. Clin Exp Immunol 121, 426-429.
7. Butt, C., Lim, S., Greenwood, C., and Rahman, P. (2007). VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis. BMC Musculoskelet Disord 8, 1.
8. Costa, C., Incio, J., and Soares, R. (2007). Angiogenesis and chronic inflammation: cause or consequence? Angiogenesis 10, 149-166.
9. Creamer, D., Sullivan, D., Bicknell, R., and Barker, J. (2002). Angiogenesis in psoriasis. Angiogenesis 5, 231-236.
10. Creamer, J.D., and Barker, J.N. (1995). Vascular proliferation and angiogenic factors in psoriasis. Clin Exp Dermatol 20, 6-9.
11. da Costa, B.R., Cevallos, M., Altman, D.G., Rutjes, A.W., and Egger, M. (2011). Uses and misuses of the STROBE statement: bibliographic study. BMJ Open 1, e000048.
12. Detmar, M., Brown, L.F., Claffey, K.P., Yeo, K.T., Kocher, O., Jackman, R.W., et al. (1994). Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 180, 1141-1146.
13. Elder, J.T. (2005). Psoriasis clinical registries, genetics, and genomics. Ann Rheum Dis 64 Suppl 2, ii106-ii107.
14. Evensen, L., Micklem, D.R., Blois, A., Berge, S.V., Aarsaether, N., Littlewood-Evans, A., et al. (2009). Mural cell associated VEGF is required for organotypic vessel formation. PLoS One 4, e5798.
15. Ferrara, N., Houck, K., Jakeman, L., and Leung, D.W. (1992). Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13, 18-32.
16. Gentilini, D., Somigliana, E., Vigano, P., Vignali, M., Busacca, M., and Di Blasio, A.M. (2008). The vascular endothelial growth factor + 405G > C polymorphism in endometriosis. Hum Reprod (Oxford, England) 23, 211-215.
17. Henseler, T., and Christophers, E. (1985). Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 13, 450-456.
18. Ho-Tin-Noe, B., and Michel, J.B. (2011). Initiation of angiogenesis in atherosclerosis: smooth muscle cells as mediators of the angiogenic response to atheroma formation. Trends Cardiovasc Med 21, 183-187.
19. Hu, K., Zhang, Y., Wang, R., Li, G., and Zhang, D. (2012). Current evidence on VEGF + 405G/C polymorphism and malignancy susceptibility: a meta-analysis involving 30 studies. Twin Res Hum Genet 15, 496-502.
20. Hubler, W.R., Jr., and Wolf, J.E., Jr. (1976). Melanoma. Tumor angiogenesis and human neoplasia. Cancer 38, 187-192.
21. Jackson, D., White, I.R., and Riley, R.D. (2012). Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med 31, 3805-3820.
22. Kunstfeld, R., Hirakawa, S., Hong, Y.K., Schacht, V., Lange-Asschenfeldt, B., Velasco, P., et al. (2004). Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia. Blood 104, 1048-1057.
23. Lambrechts, D., Storkebaum, E., Morimoto, M., Del-Favero, J., Desmet, F., Marklund, S.L., et al. (2003). VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 34, 383-394.
24. Li, C., Wang, G., Gao, Y., Liu, L., and Gao, T. (2007). TNFalpha gene promoter-238G >A and-308G >A polymorphisms alter risk of psoriasis vulgaris: a meta-analysis. Jf Invest Dermatol 127, 1886-1892.
25. Lu, X., Tang, X.F., Quan, C., Zhou, F.S., Zheng, H.F., Sun, L.D., et al. (2009). [Study on association between polymorphism of VEGF gene and psoriasis susceptibility in Chinese Han population]. Acta Univ Med Anhui 44, 318-321.
26. Malhotra, R., Stenn, K.S., Fernandez, L.A., and Braverman, I.M. (1989). Angiogenic properties of normal and psoriatic skin associate with epidermis, not dermis. Lab Invest 61, 162-165.
27. Marcoval, J., Moreno, A., Graells, J., Vidal, A., Escriba, J.M., Garcia-Ramirez, M., et al. (1997). Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase. J Cutan Pathol 24, 212-218.
28. Peters, J.L., Sutton, A.J., Jones, D.R., Abrams, K.R., and Rushton, L. (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA 295, 676-680.
29. Ragaz, A., and Ackerman, A.B. (1979). Evolution, maturation, and regression of lesions of psoriasis. New observations and correlation of clinical and histologic findings. Am J Dermatopathol 1, 199-214.
30. Rueda, B., Lopez-Nevot, M.A., Lopez-Diaz, M.J., Garcia-Porrua, C., Martin, J., and Gonzalez-Gay, M.A. (2005). A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis. J Rheumatol 32, 1737-1741.
31. Rueda, B., Perez-Armengol, C., Lopez-Lopez, S., Garcia-Porrua, C., Martin, J., and Gonzalez-Gay, M.A. (2006). Association between functional haplotypes of vascular endothelial growth factor and renal complications in Henoch-Schonlein purpura. J Rheumatol 33, 69-73.
32. Ruggiero, D., Dalmasso, C., Nutile, T., Sorice, R., Dionisi, L., Aversano, M., et al. (2011). Genetics of VEGF serum variation in human isolated populations of cilento: importance of VEGF polymorphisms. PLoS One 6, e16982.
33. Schon, M.P., Boehncke, W.H., and Brocker, E.B. (2005). Psoriasis: clinical manifestations, pathogenesis and therapeutic perspectives. Discov Med 5, 253-258.
34. Shahbazi, M., Fryer, A.A., Pravica, V., Brogan, I.J., Ramsay, H.M., Hutchinson, I.V., et al. (2002). Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 13, 260-264.
35. Trembath, R.C., Clough, R.L., Rosbotham, J.L., Jones, A.B., Camp, R.D., Frodsham, A., et al. (1997). Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Molr Genet 6, 813-820.
36. Wang, Z., Liang, W., Zhang, B., Lv, M., Wang, J., and Zhang, L. (2008). Single nucleotide polymorphisms of VEGF gene and Psoriasis risk. J Dermatol Sci 49, 263-265.
37. Watson, C.J., Webb, N.J., Bottomley, M.J., and Brenchley, P.E. (2000). Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12, 1232-1235.
38. Wongpiyabovorn, J., Yooyongsatit, S., Ruchusatsawat, K., Avihingsanon, Y., and Hirankarn, N. (2008). Association of the CTG (-2578/-460/ + 405) haplotype within the vascular endothelial growth factor gene with early-onset psoriasis. Tissue Antigens 72, 458-463.
39. Wu, D., Wu, Y., Liu, J.L., Wang, B., and Zhang, X.D. (2011). Association between HLA-Cw0602 polymorphism and psoriasis risk: a meta-analysis. Genet Mol Res 10, 3109-3120.
40. Wu, J., Ren, X., Zhang, X., Li, C., Li, Y., Ma, H., et al. (2010). The vascular endothelial growth factor + 405 G/C polymorphism in psoriasis. J Dermatol Sci 57, 62-63.
41. Xu, H.L., Tan, H.N., Wang, F.S., and Tang, W. (2008). Research advances of endostatin and its short internal fragments. Curr Protein Pept Sci 9, 275-283.
42. Xu, J., Huang, C.Z., Huang, C.B., Qiao, Z.X., and Sun, W.J. (2013). Association between the single nucleotide polymor-phism in vascular endothelial growth factor gene and susceptibility of psoriasis. Prog Mod Biomed 13, 678-680.
43. Young, H.S., Summers, A.M., Bhushan, M., Brenchley, P.E., and Griffiths, C.E. (2004). Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset. J Invest Dermatol 122, 209-215.
44. Young, H.S., Summers, A.M., Read, I.R., Fairhurst, D.A., Plant, D.J., Campalani, E., et al. (2006). Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis. J Invest Dermatol 126, 453-459.
45. Zablotna, M., Sobjanek, M., Nedoszytko, B., Lange, M., Kozicka, D., Glen, J., et al. (2013). Association of psoriasis with the VEGF gene polymorphism in the northern Polish population. J Eur Acad Dermatol Venereol 27, 319-323.
46. Zhu, K.J., Zhu, C.Y., Shi, G., and Fan, Y.M. (2012). Association of IL23R polymorphisms with psoriasis and psoriatic arthritis: a meta-analysis. Inflamm Res 61, 1149-1154.
47. Zintzaras, E., and Ioannidis, J.P. (2005). Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol 28, 123-137.